Press Release: Clinical Study in UK to Evaluate ReGenerCell(TM) for Diabetic Foot Ulcer Treatment Tuesday, May 31st, 2016 Quote: NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM — (Marketwired) — May 30, 2016 — Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY) Study will evaluate preliminary safety and effectiveness in a cohort of up to 24 patients Innovative regenerative technology will use patients' own skin cells to try to close chronic Diabetic Foot Ulcer (DFUs)… ReGenerCell for diabetic foot ulcers
View post:
ReGenerCell for diabetic foot ulcers